Junwei Liu

580 total citations
27 papers, 435 citations indexed

About

Junwei Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junwei Liu has authored 27 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Junwei Liu's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Junwei Liu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Junwei Liu collaborates with scholars based in China, United States and Belgium. Junwei Liu's co-authors include Yi Lü, Joseph C. Wu, Dong‐Sheng Huang, Mei Huang, Patricia K. Nguyen, Robert C. Robbins, Yongquan Gong, Divya Nag, Zongjin Li and Fangjun Jia and has published in prestigious journals such as Circulation, ACS Applied Materials & Interfaces and Advanced Science.

In The Last Decade

Junwei Liu

25 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junwei Liu China 11 220 110 94 87 74 27 435
Benjamin L. Emmink Netherlands 10 286 1.3× 183 1.7× 58 0.6× 228 2.6× 45 0.6× 14 519
Haixing Ju China 10 292 1.3× 187 1.7× 89 0.9× 166 1.9× 35 0.5× 26 527
Taisuke Hoshi Japan 6 176 0.8× 90 0.8× 35 0.4× 75 0.9× 44 0.6× 12 395
Andrea Pretta Italy 12 182 0.8× 139 1.3× 61 0.6× 272 3.1× 44 0.6× 47 478
Biao Zheng China 10 126 0.6× 77 0.7× 71 0.8× 184 2.1× 43 0.6× 28 373
Yasushi Shibasaki Japan 10 137 0.6× 108 1.0× 99 1.1× 105 1.2× 63 0.9× 27 422
Hai Li China 9 130 0.6× 56 0.5× 59 0.6× 121 1.4× 41 0.6× 19 356
Kosuke Yoshida Japan 14 231 1.1× 178 1.6× 60 0.6× 103 1.2× 52 0.7× 56 496
Yamin Zhang China 12 116 0.5× 58 0.5× 116 1.2× 57 0.7× 59 0.8× 37 339
Stephanie Annett Ireland 12 252 1.1× 98 0.9× 35 0.4× 169 1.9× 56 0.8× 16 495

Countries citing papers authored by Junwei Liu

Since Specialization
Citations

This map shows the geographic impact of Junwei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwei Liu more than expected).

Fields of papers citing papers by Junwei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junwei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwei Liu. The network helps show where Junwei Liu may publish in the future.

Co-authorship network of co-authors of Junwei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Junwei Liu. A scholar is included among the top collaborators of Junwei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junwei Liu. Junwei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Junwei, Yibin Zhao, Yuezhe Li, et al.. (2025). CRCFound: A Colorectal Cancer CT Image Foundation Model Based on Self‐Supervised Learning. Advanced Science. 12(41). e07339–e07339.
2.
Yu, Yang, Siyu Liu, Liming Jin, et al.. (2025). The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection. Journal of Hepatocellular Carcinoma. Volume 12. 183–192. 2 indexed citations
3.
Jin, Liming, Fangqiang Wei, Wenfeng Lu, et al.. (2024). Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy. BMC Cancer. 24(1). 1241–1241. 3 indexed citations
4.
Cosenza‐Contreras, Miguel, Niko Pinter, Manuel Rogg, et al.. (2024). TermineR: Extracting information on endogenous proteolytic processing from shotgun proteomics data. PROTEOMICS. 24(19). e2300491–e2300491. 11 indexed citations
5.
6.
Du, C. M., Zhenyu Gao, Wenfeng Lu, et al.. (2024). Prognostic value of the Naples prognostic score in patients with intrahepatic cholangiocarcinoma after hepatectomy. BMC Cancer. 24(1). 727–727. 6 indexed citations
9.
Han, Fang, Junwei Liu, Dan Cao, et al.. (2022). Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma. Frontiers in Oncology. 12. 860084–860084. 6 indexed citations
10.
Liu, Junwei, Cheng-Wu Zhang, Zunqiang Xiao, et al.. (2022). Clinicopathological study of gastric schwannoma and review of related literature. BMC Surgery. 22(1). 159–159. 16 indexed citations
11.
Lü, Yi, Lijun Liang, Guo‐Liang Shen, et al.. (2022). Theoretical Investigation of Chitosan-Assisted Controlled Release of Digestive System Antitumor Drug Fluorouracil. Journal of Pharmaceutical Sciences. 111(7). 2049–2055. 4 indexed citations
12.
Shen, Guo‐Liang, Hao Wang, Qiliang Lu, et al.. (2022). HIF-1/2α-Activated RNF146 Enhances the Proliferation and Glycolysis of Hepatocellular Carcinoma Cells via the PTEN/AKT/mTOR Pathway. Frontiers in Cell and Developmental Biology. 10. 893888–893888. 12 indexed citations
13.
Liu, Junwei, Fang Han, Xiaodong Liang, et al.. (2021). Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis. BioMed Research International. 2021(1). 8849415–8849415. 12 indexed citations
14.
Zhang, Zhaofeng, Yan Gu, Xinyue Wang, et al.. (2020). DNA methylation profiling in recurrent miscarriage. PeerJ. 8. e8196–e8196. 6 indexed citations
15.
Liu, Junwei, Siyu Wu, Xiaoyu Xie, Ziming Wang, & Qianqian Lei. (2020). The role of significantly deregulated MicroRNAs in osteosarcoma based on bioinformatic analysis. Technology and Health Care. 29(2). 333–341. 5 indexed citations
17.
Fu, Yan, Xiao Xu, Dongsheng Huang, et al.. (2017). Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial. EBioMedicine. 24. 56–63. 87 indexed citations
18.
Zhang, Jungang, Defei Hong, Ying Shi, et al.. (2014). Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy‐induced stress. Cancer Science. 105(4). 445–454. 37 indexed citations
19.
Liu, Junwei, et al.. (2013). Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer. Oncology Reports. 31(3). 1191–1198. 41 indexed citations
20.
Hu, Shijun, Mei Huang, Patricia K. Nguyen, et al.. (2011). Novel MicroRNA Prosurvival Cocktail for Improving Engraftment and Function of Cardiac Progenitor Cell Transplantation. Circulation. 124(11_suppl_1). S27–34. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026